IGF1 and hepatocellular carcinoma: Chen et al., in their in vitro studies, showed anticancer activities of the rtEa4-peptide (hEb peptide), as well as some of the mechanisms of action of this IGF1 isoform in well differentiated human HCC cell line (HepG2 cells) (e.g., inhibition of anchorage-independent growth) [169].